The invention provides methods and medicaments for improving attentiveness in humans, including subjects diagnosed with attention disorders. In one aspect, a GABA<SUB>B </SUB>receptor antagonist, such as 3-aminopropyl-(n-butyl)-phosphinic acid (ABPA), is used to improve attention.
Treatment of attention disorders